by GlobeNewsWire | Aug 26, 2015 | Biotech, Client News, Globe Newswire, Health, Medical Stocks
SAN FRANCISCO and GENEVA, Aug. 26, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan indications and neurology, announced that its 2015 Annual...